Core Viewpoint - ASP Isotopes Inc. is hosting an Institutional Investor Access Event in South Africa from November 11-13, 2025, to showcase its advancements in isotope production technology and engage with investors [1][3]. Company Overview - ASP Isotopes Inc. is a development stage advanced materials company focused on producing isotopes for various industries, employing proprietary Aerodynamic Separation Process (ASP technology) [6]. - The company aims to enrich isotopes for healthcare, technology, and nuclear energy sectors, with facilities located in Pretoria, South Africa [7]. Event Details - The event will include scientific sessions, plant tours, and opportunities for Q&A with the management and scientific teams [4]. - Investors are responsible for their own travel expenses, and registration is subject to availability and company discretion [3][5]. - Attendees must submit a passport copy by October 21, 2025, for security clearance to visit the facilities [3]. Industry Context - There is a growing demand for isotopes such as Silicon-28 for quantum computing and various isotopes for emerging healthcare and green energy applications [8].

Core Points - ASP Isotopes Inc. has appointed Robert Ainscow as Interim CEO while Paul Mann takes a temporary leave of absence for health reasons [1][3] - Michael Cunniffe has been appointed as CFO of Quantum Leap Energy LLC, effective October 1, 2025 [6][7] Company Leadership Changes - Paul Mann will transition to the role of Executive Chairman, focusing on overall leadership and strategic direction [2] - Robert Ainscow, co-founder and current COO, will manage CEO responsibilities and maintain key industry relationships during Mann's recovery [5][4] Health Update - Paul Mann underwent successful orthopedic surgery on September 19, 2025, but his recovery may take several months [3] Upcoming Investor Events - ASP Isotopes will host an Institutional Investor Access Event in South Africa on November 12 and 13, 2025 [9] - The company plans to provide quarterly business updates starting in November 2025 [11] Company Overview - ASP Isotopes Inc. focuses on developing technology for isotope production, particularly for healthcare and technology industries [12] - The company employs proprietary Aerodynamic Separation Process technology and has facilities in Pretoria, South Africa [12][13]

Core Viewpoint - ASP Isotopes Inc. is hosting an Investor Access Event in South Africa from June 16-18, 2025, to enhance transparency and communication with stakeholders [1][3]. Event Details - The event will include scientific sessions and plant tours, allowing investors to see the company's enrichment production plants and meet the management and scientific teams [4][5]. - An additional day for visiting the Renergen Virginia Gas Project is available on June 19, 2025, subject to availability [2]. Company Progress - As of April 2025, ASP Isotopes is commercially enriching Carbon-14 and Silicon-28, with the Ytterbium-176 plant producing commercial samples [4]. - The company has hosted over 60 investors and corporate clients in 2024 and a successful event in January 2025 with 27 investors from three continents [3]. Technology and Market Demand - ASP Isotopes employs proprietary Aerodynamic Separation Process technology for isotope production, focusing on healthcare and technology industries [6]. - There is a growing demand for isotopes such as Silicon-28 for quantum computing and various isotopes for emerging healthcare applications and green energy [7][8].